Axsome Therapeutics Inc (AXSM)
78.07
+0.49
(+0.63%)
USD |
NASDAQ |
May 21, 16:00
78.07
0.00 (0.00%)
After-Hours: 19:40
Axsome Therapeutics Profit Margin (Quarterly): -91.14% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -91.14% |
December 31, 2023 | -137.9% |
September 30, 2023 | -107.6% |
June 30, 2023 | -143.8% |
Date | Value |
---|---|
March 31, 2023 | -11.86% |
December 31, 2022 | -251.3% |
September 30, 2022 | -266.1% |
June 30, 2022 | -469.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-469.8%
Minimum
Jun 2022
-11.86%
Maximum
Mar 2023
-184.9%
Average
-140.9%
Median
Profit Margin (Quarterly) Benchmarks
Krystal Biotech Inc | 2.06% |
Catalyst Pharmaceuticals Inc | 23.63% |
Vertex Pharmaceuticals Inc | 40.87% |
Vistagen Therapeutics Inc | -1.54K% |
ADMA Biologics Inc | 21.75% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -148.9% |
Return on Assets | -54.17% |
Return on Invested Capital | -79.94% |
Gross Profit Margin (Quarterly) | 91.60% |
Operating Margin (Quarterly) | -91.58% |
Return on Net Operating Assets | -183.1% |